Immunosuppressants

What are immunosuppressants?

Immunosuppressants, also called immunomodulators, are conventional therapies as they have been around for a long time. They were first used in people who needed to safely receive organ transplants and it was later starting to be used to treat inflammation in people with inflammatory bowel disease.

Examples of immunosuppressants include methotrexate (e.g. Metoject®, Rheumatrex®), azathioprine (Imuran®), 6-mercaptopurine (e.g. Purinethol®) , cyclosporine (Neoral®), tacrolimus (e.g. Astagraf XL®, Envarsus XR®), and Ozanimod (Zeposia®).


Back to top

How do immunosuppressants work?

Immunomodulators work by reducing IBD inflammation. They impact the number or function of immune cells (cells of the immune system) and by doing so, they suppress the immune system in order to reduce inflammation caused by these type of cells in your body.


Thiopurines (azathiopurine, 6-mercaptopurine)

These medications kill inflammatory cells (cells that cause inflammation), called T cells, by blocking its TcR pathway responsible for cell survival.

They also block the ability of inflammatory cells to build DNA, by inhibiting the production of the chemical 'purine' found in DNA, and this prevents the production of inflammatory cells.

Methotrexate

It stops an enzyme (or a protein), called dihydrofolate reductase, from functioning. As a result, this reduces the production of DNA, RNA, thymidylates (enzymes important for DNA production), and proteins. In turn, this process leads to lower levels of inflammation.

Cyclosporine, Tacrolimus

These medications are less commonly used, but mostly among people who are hospitalized.

They work by blocking calcineurin, an enzyme or protein responsible for a type of inflammatory cells (cells that cause inflammation) called T cells. By preventing their activation, there are fewer active T cells in the body and therefore less inflammation.

Ozanimod

These medications bind to two subtypes of receptors, or proteins, called sphingosine 1-phosphate (S1P). S1P receptors are found on the surface membranes of the immune cells, T cells and B cells. 

The binding action of ozanimod prevents these immune cells from getting activated and released in the blood. In turn, this reduces the level of inflammation in people with colitis.


Back to top

Who are immunosuppressants used for?

Thiopurines: Oral pills

These medications are used to treat both Crohn's disease and ulcerative colitis. 

Some people with IBD are on these medications alone to treat their disease but also to try to reduce their need for steroids.

They can also be used in combination with biologics to improve their efficacy, e.g. people with IBD could be taking Remicade® and Imuran® at the same time. This is because sometimes two treatments are better than one as you can get a better response and the immunomodulators boost the blood levels of biologics. This combination can also reduce of developing antibodies (an immune system response) to the drugs.

These medications are also used much less frequently over time due to the long-term safety issues associated to them. 

Methothrexate: Oral pills, Subcutaneous injections (under the skin), Injections into the muscle

Methothrexate is used to treat Crohn's disease. Just like thiopurines, some people with IBD are on this medication alone to treat their disease, or in combination with biologics for the same reasons, but also to try to reduce their need for steroids.

It is also helpful for arthritis and is therefore prescribed for people with Crohn's or colitis who also have arthritis.

However, data on methothrexate in colitis has not been very convincing so far and hence, this medication is not considered effective to treat colitis when used alone.

Cyclosporine: Oral pills, Injections, IV infusions

Cyclosporine is not typically used by people with IBD, but instead it is used only rarely for people with severe colitis who are hospitalized. 

Ozanimod: Oral capsules

Ozanimod (brand name: Zeposia®) is used in the treatment of adults with moderate-to-severe, active ulcerative colitis who have had an inadequate response, loss of response, or were intolerant to either conventional therapy or a biologic medication.

It is also used to treat people with relapsing remitting multiple sclerosis (RRMS) to decrease the frequency of clinical complications.

Health Canada has not authorized the use of Zeposia® for people younger than 18 years old. 

As for people with colitis at/or greater than 65 years old, a limited number of them enrolled in the clinical trials for this medication. Within the group that participated, Zeposia® was found to be effective only to induce remission. Therefore, Health Canada has not authorized Zeposia® for maintenance therapy for people of age or older than 65 years old who have colitis.


Back to top

How effective are immunosuppressants?

Here is a summary of the effectiveness of immunosuppressants in managing active IBD and preventing relapse during remission:

Active ulcerative colitis

  • The immunosuppressants cyclosporine and ozanimod are effective at inducing remission in active UC.

  • The immunosuppressants azathioprine, 6-mercaptopurine, methotrexate, and tacrolimus are NOT effective at inducing remission in active UC.

Inactive ulcerative colitis (remission) 

  • Azathioprine and 6-mercaptopurine are effective at preventing relapse in inactive UC.

  • Methotrexate is NOT effective at preventing relapse in inactive UC.

Active Crohn's disease

  • Methotrexate is effective at inducing remission in active CD.

  • Azathioprine and 6-mercaptopurine are NOT effective at inducing remission in active CD.

Inactive Crohn's disease (remission) 

  • Azathioprine and 6-mercaptopurine are effective at preventing relapse in inactive CD.

  • Cyclosporine is NOT effective at preventing relapse in inactive CD.

Talk your health care provider or IBD specialist for more information. 


Back to top

Side effects and risks of use

General disclaimer

People on these treatments should get regular blood tests done to monitor aspects like your liver condition and your blood counts because in some patients, immunosuppressants impact the bone marrow and this leads to their levels of white blood cells (cells that are part of the immune system) to go down.

Azathioprine and 6-mercaptopurine

Adverse effects of azathioprine and 6-mercaptopurine can include nausea, allergic reactions, acute pancreatitis (inflammation of the pancreas), hepatitis (inflammation of the liver), increased risk of infection, malignancy (small but increased long-term risk of developing lymphoma and non-melanoma skin cancer), and myelosuppression (bone marrow suppression).

Bone marrow is where blood cells are made, and suppression of bone marrow means fewer white blood cells, red blood cells, or blood clotting cells in the body. As bone marrow suppression can happen anytime during therapy, patients are recommended to have regular blood tests to check for leucopenia, which is a reduction of white blood cells. 

If you develop severe flu-like symptoms or abdominal pain while taking azathioprine or 6-mercaptopurine, stop the medication and call your doctor immediately. 

Methotrexate

Adverse effects of methotrexate include hepatoxicity (liver damage), pneumonitis (inflammation of the lung), increased risk of infection, malignancy, alopecia (hair loss), stomatitis (a sore of inflammation inside the mouth), and myelosuppression.

If you develop shortness of breath and cough while on methotrexate, you might be having an allergic reaction and should call your doctor immediately.

Methotrexate is also teratogenic (contraindicated in pregnancy), meaning that pregnant people should not be taking this drug. You have to use adequate contraception and be aware that this medication can cause pregnancy loss. In fact, it was used historically to induce abortions because it has such a strong effect on pregnancy. 

This medication should be taken with folic acid to reduce some of the side effects associated with methotrexate. 

Cyclosporine and Tacrolimus

Adverse effects of cyclosporine and tacrolimus include renal toxicity (kidney damage), hypertension, hirsuitism (excessive body hair), headache, opportunistic infections (infection caused by bacteria, viruses, fungi, or protozoa), seizures, and paresthesia (tingling in the legs, arms, hands, or feet).

Ozanimod

The most common side effects of Zeposia® include upper respiratory tract infections, higher liver enzymes (inflammation or damage to liver cells), low blood pressure when you stand up (orthostatic hypotension), painful and frequent urination (signs of urinary tract infection), back pain, high blood pressure, and headache.

Immunizations and vaccinations 

If you are taking immunosuppressants, you should avoid having live vaccines from three weeks before starting this type of drug. You should not have vaccines during the time you are on immunosuppressants, up until three to six months after stopping. You should also avoid anyone who has recently had live vaccine, and avoid the nasal flu vaccine.


Back to top

Resources

Video: Immunomodulators and Inflammatory Bowel Disease

Watch this 7 min video to learn more about immunomodulators/immunosuppressants used in the treatment of Crohn's disease and ulcerative colitis, including how these medications work in IBD, what they are used for, which types of patients can access these medications, potential benefits, side effects, and risks.

Speaker: Dr. John K. Marshall (MD, MSc, FRCPC, CAGF, AGAF), Professor of Medicine, Director, Division of Gastroenterology, McMaster University.


Back to top


In This Section

Back to IBD Journey